Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting
May 27, 2022 at 09:57 AM EDT
This includes Arcellx, Iovance Biotherapeutics, and ZymeWorks.
Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting
By:
MarketWatch
May 27, 2022 at 09:57 AM EDT
This includes Arcellx, Iovance Biotherapeutics, and ZymeWorks.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|